GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:GENT - NO0010748866 - Common Stock
57.4 NOK
-1.6 (-2.71%)
We assign a fundamental rating of 6 out of 10 to GENT. GENT was compared to 68 industry peers in the Health Care Equipment & Supplies industry. While GENT has a great health rating, its profitability is only average at the moment. GENT is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
- In the past year GENT was profitable.
- In the past year GENT had a positive cash flow from operations.
- In the past 5 years GENT reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
- GENT has a Return On Assets of 18.38%. This is amongst the best in the industry. GENT outperforms 97.06% of its industry peers.
- GENT's Return On Equity of 21.18% is amongst the best of the industry. GENT outperforms 88.24% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 8.76%, GENT is in the better half of the industry, outperforming 72.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROIC | 8.76% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of GENT (24.80%) is better than 94.12% of its industry peers.
- GENT has a Operating Margin of 13.44%. This is comparable to the rest of the industry: GENT outperforms 58.82% of its industry peers.
- GENT has a Gross Margin (55.06%) which is in line with its industry peers.
- GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
- GENT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for GENT remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, GENT has about the same amount of shares outstanding.
- The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 18.91 indicates that GENT is not in any danger for bankruptcy at the moment.
- The Altman-Z score of GENT (18.91) is better than 98.53% of its industry peers.
- The Debt to FCF ratio of GENT is 0.59, which is an excellent value as it means it would take GENT, only 0.59 years of fcf income to pay off all of its debts.
- GENT's Debt to FCF ratio of 0.59 is amongst the best of the industry. GENT outperforms 92.65% of its industry peers.
- A Debt/Equity ratio of 0.01 indicates that GENT is not too dependend on debt financing.
- The Debt to Equity ratio of GENT (0.01) is better than 91.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 18.91 |
ROIC/WACC1.03
WACC8.51%
2.3 Liquidity
- GENT has a Current Ratio of 5.98. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT has a better Current ratio (5.98) than 98.53% of its industry peers.
- A Quick Ratio of 4.16 indicates that GENT has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 4.16, GENT belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 2066.40% over the past year.
- GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.42%.
- Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
3.2 Future
- GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.29% yearly.
- GENT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.72% yearly.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 21.03, the valuation of GENT can be described as rather expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a rather cheap valuation: GENT is cheaper than 80.88% of the companies listed in the same industry.
- GENT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.33.
- GENT is valuated rather expensively with a Price/Forward Earnings ratio of 21.16.
- GENT's Price/Forward Earnings ratio is in line with the industry average.
- GENT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.03 | ||
| Fwd PE | 21.16 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GENT is valued a bit more expensive than the industry average as 63.24% of the companies are valued more cheaply.
- Based on the Price/Free Cash Flow ratio, GENT is valued a bit more expensive than 63.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 272.43 | ||
| EV/EBITDA | 25.6 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- GENT's earnings are expected to grow with 62.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- GENT has a yearly dividend return of 0.69%, which is pretty low.
- GENT's Dividend Yield is comparable with the industry average which is at 1.13.
- Compared to an average S&P500 Dividend Yield of 1.91, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (1/14/2026, 3:51:37 PM)
57.4
-1.6 (-2.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners2.6%
Ins Owner ChangeN/A
Market Cap885.11M
Revenue(TTM)172.52M
Net Income(TTM)42.78M
Analysts85.71
Price Target68.34 (19.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.03 | ||
| Fwd PE | 21.16 | ||
| P/S | 5.13 | ||
| P/FCF | 272.43 | ||
| P/OCF | 71.38 | ||
| P/B | 4.38 | ||
| P/tB | 5.21 | ||
| EV/EBITDA | 25.6 |
EPS(TTM)2.73
EY4.76%
EPS(NY)2.71
Fwd EY4.73%
FCF(TTM)0.21
FCFY0.37%
OCF(TTM)0.8
OCFY1.4%
SpS11.19
BVpS13.1
TBVpS11.01
PEG (NY)0.35
PEG (5Y)N/A
Graham Number28.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROCE | 11.37% | ||
| ROIC | 8.76% | ||
| ROICexc | 15.22% | ||
| ROICexgc | 21.01% | ||
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% | ||
| FCFM | 1.88% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.06 | ||
| Cap/Depr | 101.32% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 38.48% | ||
| Profit Quality | 7.6% | ||
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 | ||
| Altman-Z | 18.91 |
F-Score5
WACC8.51%
ROIC/WACC1.03
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y260.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y127.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.08%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 4 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
How financially healthy is GENTIAN DIAGNOSTICS ASA?
The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.